Korean Drug (Korea) Price on September 23, 2024
| 014570 Stock | KRW 4,610 5.00 0.11% |
If you're considering investing in Korean Stock, it is important to understand the factors that can impact its price. As of today, the current price of Korean Drug stands at 4,610, as last reported on the 29th of November, with the highest price reaching 4,630 and the lowest price hitting 4,590 during the day. Korean Drug has Sharpe Ratio of -0.17, which conveys that the firm had a -0.17% return per unit of risk over the last 3 months. Korean Drug exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Korean Drug's Risk Adjusted Performance of (0.15), standard deviation of 1.45, and Mean Deviation of 1.02 to check out the risk estimate we provide.
Korean Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Korean |
Sharpe Ratio = -0.1679
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 014570 |
Estimated Market Risk
| 1.39 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.23 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Korean Drug is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Korean Drug by adding Korean Drug to a well-diversified portfolio.
Korean Drug Valuation on September 23, 2024
It is possible to determine the worth of Korean Drug on a given historical date. On September 23, 2024 Korean was worth 5130.0 at the beginning of the trading date compared to the closed value of 5160.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Korean Drug stock. Still, in general, we apply an absolute valuation method to find Korean Drug's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Korean Drug where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Korean Drug's related companies.
| Open | High | Low | Close | Volume | |
| 5,080 | 5,170 | 5,060 | 5,150 | 10,511 | |
09/23/2024 | 5,130 | 5,170 | 5,100 | 5,160 | 8,410 |
| 5,150 | 5,160 | 5,070 | 5,130 | 9,142 |
| Backtest Korean Drug | | | Korean Drug History | | | Korean Drug Valuation | Previous | Next |
Korean Drug Trading Date Momentum on September 23, 2024
| On September 24 2024 Korean Drug Co was traded for 5,130 at the closing time. The highest price during the trading period was 5,160 and the lowest recorded bid was listed for 5,070 . The volume for the day was 9.1 K. This history from September 24, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 0.58% . The trading delta at closing time to the current price is 2.91% . |
Korean Drug Fundamentals Correlations and Trends
By evaluating Korean Drug's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Korean Drug's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Korean financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Korean Drug Stock history
Korean Drug investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Korean is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Korean Drug will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Korean Drug stock prices may prove useful in developing a viable investing in Korean Drug
Korean Drug Co., Ltd. researches, develops, manufactures, and markets medicines for treating human illness in South Korea. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea. KOREAN DRUG is traded on Korean Securities Dealers Automated Quotations in South Korea.
Korean Drug Stock Technical Analysis
Korean Drug technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Korean Drug Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Korean Drug Co cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Korean Drug November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Korean Drug stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Korean Drug shares will generate the highest return on investment. By undertsting and applying Korean Drug stock market strength indicators, traders can identify Korean Drug Co entry and exit signals to maximize returns
Korean Drug Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Korean Drug's price direction in advance. Along with the technical and fundamental analysis of Korean Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Korean to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.52) | |||
| Treynor Ratio | (2.95) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Korean Stock analysis
When running Korean Drug's price analysis, check to measure Korean Drug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Korean Drug is operating at the current time. Most of Korean Drug's value examination focuses on studying past and present price action to predict the probability of Korean Drug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Korean Drug's price. Additionally, you may evaluate how the addition of Korean Drug to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |